Literature DB >> 2227358

Factors involved in the electroporation-induced transformation of Clostridium perfringens.

S P Allen1, H P Blaschek.   

Abstract

The following factors were found to improve the efficiency of transformation of Clostridium perfringens 3624A Rifr Strr: (1) a reduction in cuvette sample volume (DNA and cell suspension) to 0.8 ml, (2) use of a 1 microgram/ml concentration of transforming DNA, (3) use of late-logarithmic phase cells, (4) 3-fold concentration of cell density (3.0 x 10(8) CFU/ml), and (5) a reduction in the pH of the expression and selective plating medium to 6.4. Application of the improved conditions resulted in transformation efficiencies for C. perfringens 3624A Rifr Strr ranging from 7.1 transformants/microgram DNA for plasmic pIP401 to 9.2 x 10(4) transformants per microgram DNA for plasmid pAK201. The greatest transformation efficiency obtained using pAK201 was 9.8 x 10(6) transformants/micrograms DNA for C. perfringens strain 13. Using the improved protocol, pAM beta 1 was transformed at a 42-fold greater level when compared with the values reported earlier [1]. In addition to C. perfringens 3624A Rifr Strr, strains 13, 10543A, 3628C, NTG-4, and 3624A were successfully transformed. Nuclease does not appear to be a factor in the C. perfringens strain-specific electro-transformation protocol.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2227358     DOI: 10.1111/j.1574-6968.1990.tb13981.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  10 in total

Review 1.  Cellulase, clostridia, and ethanol.

Authors:  Arnold L Demain; Michael Newcomb; J H David Wu
Journal:  Microbiol Mol Biol Rev       Date:  2005-03       Impact factor: 11.056

2.  Construction and characterization of a lactose-inducible promoter system for controlled gene expression in Clostridium perfringens.

Authors:  Andrea H Hartman; Hualan Liu; Stephen B Melville
Journal:  Appl Environ Microbiol       Date:  2010-11-19       Impact factor: 4.792

3.  Electrotransformation of Clostridium thermosaccharolyticum.

Authors:  T R Klapatch; M L Guerinot; L R Lynd
Journal:  J Ind Microbiol       Date:  1996-06

4.  Regulated expression of Clostridium perfringens enterotoxin in naturally cpe-negative type A, B, and C isolates of C. perfringens.

Authors:  J R Czeczulin; R E Collie; B A McClane
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

5.  Clostridium difficile MazF toxin exhibits selective, not global, mRNA cleavage.

Authors:  Francesca P Rothenbacher; Motoo Suzuki; Jennifer M Hurley; Thomas J Montville; Thomas J Kirn; Ming Ouyang; Nancy A Woychik
Journal:  J Bacteriol       Date:  2012-04-27       Impact factor: 3.490

6.  Expression from the Clostridium perfringens cpe promoter in C. perfringens and Bacillus subtilis.

Authors:  S B Melville; R Labbe; A L Sonenshein
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Generation of single-copy transposon insertions in Clostridium perfringens by electroporation of phage mu DNA transposition complexes.

Authors:  A Lanckriet; L Timbermont; L J Happonen; M I Pajunen; F Pasmans; F Haesebrouck; R Ducatelle; H Savilahti; F Van Immerseel
Journal:  Appl Environ Microbiol       Date:  2009-03-06       Impact factor: 4.792

Review 8.  Molecular genetics and pathogenesis of Clostridium perfringens.

Authors:  J I Rood; S T Cole
Journal:  Microbiol Rev       Date:  1991-12

9.  Purification, characterization, and primary structure of Clostridium perfringens lambda-toxin, a thermolysin-like metalloprotease.

Authors:  F Jin; O Matsushita; S Katayama; S Jin; C Matsushita; J Minami; A Okabe
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

10.  The virR gene, a member of a class of two-component response regulators, regulates the production of perfringolysin O, collagenase, and hemagglutinin in Clostridium perfringens.

Authors:  T Shimizu; W Ba-Thein; M Tamaki; H Hayashi
Journal:  J Bacteriol       Date:  1994-03       Impact factor: 3.490

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.